HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Michael Steurer Selected Research
Michael Steurer Research Topics
Disease
15
Neoplasms (Cancer)
01/2021 - 02/2003
8
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2020 - 06/2004
6
Infections
01/2019 - 08/2006
5
Hairy Cell Leukemia
01/2019 - 01/2016
5
Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2018 - 02/2012
5
Hemorrhage
01/2018 - 11/2004
4
Lymphoma (Lymphomas)
01/2016 - 04/2008
3
Thrombosis (Thrombus)
03/2018 - 04/2003
3
Essential Thrombocythemia
06/2015 - 02/2009
3
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2015 - 04/2003
2
Multiple Myeloma
12/2020 - 06/2004
2
Neutropenia
07/2016 - 09/2011
2
Thrombocytosis (Thrombocythemia)
02/2009 - 11/2004
1
Chromosome Aberrations (Chromosome Abnormalities)
12/2020
1
Atrial Fibrillation
02/2020
1
Meningitis
12/2019
1
Intraocular Lymphoma
01/2019
1
Myelitis
01/2019
1
Obesity
01/2019
1
Residual Neoplasm
10/2018
1
Hemophilia A (Haemophilia)
03/2017
1
Pulmonary Hypertension
01/2017
1
Hemoglobinopathies
01/2017
1
Brain Neoplasms (Brain Tumor)
01/2016
1
Iron Deficiencies
12/2015
1
Leukemia
01/2015
1
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
09/2014
1
Sepsis (Septicemia)
09/2014
1
Amyloidosis
03/2014
1
Ischemia
03/2014
1
Venous Thrombosis (Deep-Vein Thrombosis)
03/2014
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2014
1
Lymphoid Leukemia
12/2013
1
Weight Gain
12/2013
1
Liver Diseases (Liver Disease)
12/2013
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2013
1
Pancreatic Neoplasms (Pancreatic Cancer)
12/2012
1
Neoplasm Metastasis (Metastasis)
12/2012
1
Adenocarcinoma
12/2012
1
Hypereosinophilic Syndrome (Loeffler Endocarditis)
11/2012
1
Pruritus (Itching)
11/2012
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2012
1
Plasma Cell Granuloma
01/2012
1
Exanthema (Rash)
09/2011
Drug/Important Bio-Agent (IBA)
6
Rituximab (Mabthera)
FDA Link
10/2019 - 07/2003
5
anagrelide (Agrylin)
FDA Link
Generic
03/2018 - 11/2004
4
Inosine Triphosphate (ITP)
IBA
01/2018 - 02/2012
3
ibrutinib
IBA
02/2020 - 01/2017
3
romiplostim
FDA Link
02/2017 - 01/2015
3
Proteins (Proteins, Gene)
FDA Link
12/2013 - 04/2008
2
Bendamustine Hydrochloride
FDA Link
10/2019 - 09/2015
2
Vemurafenib
IBA
01/2019 - 01/2016
2
Hemostatics (Antihemorrhagics)
IBA
01/2018 - 06/2015
2
ofatumumab
FDA Link
01/2016 - 12/2013
2
Iron
IBA
12/2015 - 12/2015
2
N 30
IBA
08/2008 - 04/2008
2
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
10/2006 - 02/2003
1
Immunoglobulins (Immunoglobulin)
IBA
12/2020
1
Cytarabine (Cytosar-U)
FDA Link
Generic
12/2019
1
Delayed-Action Preparations
IBA
12/2019
1
Chemokines
IBA
10/2019
1
pomalidomide
IBA
01/2019
1
Immunoglobulin Variable Region
IBA
10/2018
1
recombinant factor VIII N8
IBA
03/2017
1
Factor VIII (Coagulation Factor VIII)
IBA
03/2017
1
Thrombopoietin Receptors
IBA
01/2017
1
Calreticulin
IBA
08/2016
1
fludarabine
IBA
01/2016
1
Interferons
IBA
01/2016
1
obinutuzumab
IBA
01/2016
1
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
01/2016
1
Cytokines
IBA
12/2015
1
Troponin I
IBA
06/2015
1
pro-brain natriuretic peptide (1-76)
IBA
06/2015
1
Caspases
IBA
01/2015
1
Collagen Type I (Type I Collagen)
IBA
01/2015
1
Brentuximab Vedotin
IBA
09/2014
1
Retinaldehyde (Retinal)
IBA
03/2014
1
Crizotinib
IBA
02/2014
1
Anaplastic Lymphoma Kinase
IBA
02/2014
1
Monoclonal Antibodies
IBA
12/2013
1
Complement System Proteins (Complement)
IBA
12/2013
1
Triglycerides (Triacylglycerol)
IBA
12/2013
1
Propidium (Propidium Iodide)
IBA
12/2013
1
Complement Factor H (Factor H)
IBA
12/2013
1
Phospholipases (Phospholipase)
IBA
12/2013
1
Azacitidine (5 Azacytidine)
FDA Link
01/2013
1
Biomarkers (Surrogate Marker)
IBA
12/2012
1
Glycoproteins (Glycoprotein)
IBA
12/2012
1
Paraffin
IBA
12/2012
1
Antigens
IBA
12/2012
1
Junctional Adhesion Molecule A
IBA
12/2012
Therapy/Procedure
6
Therapeutics
01/2021 - 11/2012
2
Liver Transplantation
09/2014 - 12/2013
2
Drug Therapy (Chemotherapy)
02/2014 - 06/2004
2
Stem Cell Transplantation
07/2012 - 07/2003
1
Hematopoietic Stem Cell Transplantation
01/2017
1
Splenectomy
01/2017
1
Phototherapy (Light Therapy)
11/2012
1
Immunomodulation
01/2012